Microbleeds in atypical presentations of Alzheimer's disease: a comparison to dementia of the Alzheimer's type

Manuscript Number: 

14-2628R1

Author(s): 
Daniel A. Drubach, Joseph R. Duffy, Jeffrey L. Gunter, Clifford R. Jack Jr., Keith A. Josephs, Kejal Kantarci, Val J. Lowe, Emily S. Lundt, Mary M. Machulda, Ronald C. Petersen, Anthony J. Spychalla, Edythe A. Strand, Stephen D. Weigand, Jennifer L. Whitwell

Disclosures

Daniel A. Drubach

  • Nothing to Disclose

Joseph R. Duffy

  • Nothing to Disclose

Jeffrey L. Gunter

  • Nothing to Disclose

Clifford R. Jack Jr.

  • Consulting Fees:
    Dr. Jack serves as a consultant for Janssen Research & Development, LLC and Eli Lilly

Keith A. Josephs

  • Nothing to Disclose

Kejal Kantarci

  • Consulting Fees:
    Data Safety Monitoring Board Pfizer and Jannsen Alzheimer Immunotherapy Data Safety Monitoring Board Takeda Inc.

Val J. Lowe

  • Lecture Fees:
    Piramal Imaging, fees for speaking in 2014 at one event.
    Grants
    • Agency: 
      GE Health Care
      Dates: 
      6/209-6/2015
    • Agency: 
      Siemens Molecular Imaging
      Dates: 
      6/2005-present
    • Agency: 
      Avid Radiopharmaceuticals
      Dates: 
      1/2011-present

Emily S. Lundt

  • Nothing to Disclose

Mary M. Machulda

  • Nothing to Disclose

Ronald C. Petersen

  • Consulting Fees:
    Dr. Petersen serves as Chair on the Data Monitoring Committee for Pfizer, Inc. and Janssen Alzheimer Immunotherapy, and serves as a consultant to Roche Inc., Merck and Genentech.

Anthony J. Spychalla

  • Nothing to Disclose

Edythe A. Strand

  • Nothing to Disclose

Stephen D. Weigand

  • Nothing to Disclose

Jennifer L. Whitwell

  • Nothing to Disclose